Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
N/A
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Polaryx Therapeutics, Inc. Common Stock
Market Cap
$104.68M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$104.26M
Gross Margin
71.67%
TTM Avg
77.09%
3Y Avg
79.04%
5Y Avg
77.65%
Market Cap
$103.14M
Gross Margin
99.54%
TTM Avg
49.77%
3Y Avg
24.89%
5Y Avg
16.59%
Market Cap
$102.75M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
5.83%
5Y Avg
8.02%
Market Cap
$106.93M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$106.96M
Gross Margin
46.49%
TTM Avg
23.25%
3Y Avg
11.62%
5Y Avg
7.75%
Market Cap
$106.98M
Gross Margin
83.37%
TTM Avg
83.81%
3Y Avg
82.64%
5Y Avg
80.50%
Market Cap
$107.09M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
2.35%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Polaryx Therapeutics, Inc. Common Stock (PLYX) | $104.68M | 0.00% | 0.00% | N/A | N/A |
| Definitive Healthcare Corp. (DH)vs › | $104.26M | 71.67% | 77.09% | 79.04% | 77.65% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $103.14M | 99.54% | 49.77% | 24.89% | 16.59% |
| Immunic, Inc. (IMUX)vs › | $106.52M | 0.00% | 0.00% | 0.00% | 0.00% |
| Anixa Biosciences, Inc. (ANIX)vs › | $102.75M | 0.00% | 0.00% | 5.83% | 8.02% |
| Vivani Medical, Inc. (VANI)vs › | $106.93M | 0.00% | 0.00% | 0.00% | 0.00% |
| Outlook Therapeutics, Inc. (OTLK)vs › | $106.96M | 46.49% | 23.25% | 11.62% | 7.75% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.98M | 83.37% | 83.81% | 82.64% | 80.50% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $107.09M | 0.00% | 0.00% | 0.00% | 2.35% |
| Apyx Medical Corporation (APYX)vs › | $107.17M | 33.94% | 48.53% | 56.75% | 59.91% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
